Defective cell cycle checkpoint functions in melanoma are associated with altered patterns of gene expression

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• DNA damage response (DDR) pathways are crucial for maintaining genomic stability.
• Defects in DDR are implicated in cancer development, including melanoma.
• Cell cycle checkpoints prevent proliferation of cells with damaged DNA.

Purpose of the Study:

• To investigate if gene expression patterns can predict DNA damage checkpoint function in melanoma.
• To identify specific gene expression signatures associated with checkpoint defects.
• To compare predictive accuracy of different analytical tools for checkpoint function.

Main Methods:

• Analysis of gene expression profiles in normal human melanocytes (NHMs) and melanoma cell lines.
• Assessment of G1 and G2 cell cycle checkpoint responses to ionizing radiation.
• Application of Bayesian analysis and significance analysis of microarrays (SAM) for data interpretation.

Main Results:

• NHMs exhibited functional G1 and G2 checkpoints.
• 11 out of 16 melanoma cell lines showed defects in one or both checkpoints.
• Melanomas with B-RAF mutations had impaired G2 checkpoints; epithelial-like melanomas with wild-type RAS/RAF had impaired G1 checkpoints.
• Gene expression profiling revealed reduced p53 target genes (e.g., CDKN1A, DDB2) and increased proliferation genes (e.g., CDC7, GEMININ) in melanomas with G1 checkpoint defects.
• Bayesian analysis demonstrated higher accuracy than SAM in predicting checkpoint function.

Conclusions:

• Melanoma cells frequently display defects in DNA damage-induced cell cycle checkpoints.
• Gene expression profiling can identify melanomas with impaired DNA damage responses.
• These findings suggest a potential role for gene expression analysis in recognizing and characterizing DNA damage checkpoint deficiencies in melanoma.